Abstract
A case study is presented to demonstrate the presumed effects of a quality of life claim on the sales performance of a prescription pharmaceut~cal. Using the Gompertz curve, it was possible to lot the sales of the product, Capoten", before expansion of the fie~lforce, expansion of labeling, and addition of a quality of life claim. The changes are calculated to have resulted in an additional $375 million in sales.